Cryopreserved versus non-cryopreserved peripheral blood stem cells for autologous transplantation after high-dose Melphalan in multiple myeloma: comparative analysis

Bone Marrow Transplant. 2019 Jan;54(1):138-141. doi: 10.1038/s41409-018-0250-1. Epub 2018 Aug 14.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter

MeSH terms

  • Autografts
  • Cryopreservation*
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Melphalan / administration & dosage*
  • Middle Aged
  • Multiple Myeloma / blood
  • Multiple Myeloma / mortality*
  • Multiple Myeloma / therapy*
  • Peripheral Blood Stem Cell Transplantation*
  • Peripheral Blood Stem Cells*
  • Retrospective Studies
  • Survival Rate

Substances

  • Melphalan